Antibacterial activity of a newly identified phage-derived endolysin and its parental bacteriophage against clinical uropathogenic Escherichia coli
- 1Department of Molecular Biology, Faculty of Biology, University of Gdansk
Abstract
The increasing prevalence of antibiotic-resistant uropathogenic Escherichia coli highlights the need for antibacterial strategies that can complement or extend beyond conventional antibiotic treatment. Bacteriophages and phage-derived lytic enzymes represent promising alternatives because of their distinct mechanisms of bacterial killing and their potential activity against drug-resistant pathogens. In this study, we characterized the newly discovered UPEC-infecting bacteriophage vB-EcoS_57-3 and the endolysin 57_3Lys, encoded by this phage, combining genomic, structural, and functional approaches. The phage demonstrated lytic activity against clinical UPEC isolates and retained antibacterial potential under conditions relevant to the urinary tract. Genomic and sequence analyses revealed distinctive features of 57_3Lys associated with signal-anchor-release endolysins and suggested a less common mode of intracellular translocation and activation. Functional experiments supported the involvement of the bacterial secretion machinery in endolysin-mediated lysis. Notably, the purified enzyme also displayed antibacterial activity against intact clinical E. coli cells, despite the intrinsic barrier presented by the Gram-negative cell envelope. Although this activity developed slowly, it significantly reduced both bacterial culture turbidity and viable cell number. Together, these findings provide new insights into the antimicrobial strategies based on the phages and their phage lytic enzymes, supporting further exploration of vB-EcoS_57-3 and 57_3Lys as potential tools against antibiotic-resistant UPEC.
Related
- Transcriptomic insights into the effects of sublethal exposure to endolysin LNT113 on Escherichia coli
- Phenotypic Characterization of OXA-439, an OXA-163 variant, isolated from uropathogenic Escherichia coli
- Bacterial strategies for surviving antibiotics during urinary tract infection: could uropathogenic Escherichia coli be persisters?
- Isolation and phenotypic characterization of bacteriophages targeting multidrug-resistant biofilm-forming uropathogenic Escherichia coli from hospital sewage
- Cross-species convergence of surface polysaccharides shapes the virulence of an atypical carbapenem resistant uropathogenic Escherichia coli clone
BibTeX
@misc{wesolowski2026antibacterial,
title = {{Antibacterial activity of a newly identified phage-derived endolysin and its parental bacteriophage against clinical uropathogenic Escherichia coli}},
author = {W. Wesolowski and S. Bloch and G. Czerwonka and E. Jagiela and L. Grabowski and M. Jeschke and J. Jacewicz and E. Piwnicka and J. Morcinek-Orlowska and H. Loika and P. Czaplewska and G. Wegrzyn and W. Adamus-Bialek and A. Lukasiak and B. Nejman-Falenczyk},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.09.750462},
url = {https://www.biorxiv.org/content/10.64898/2026.09.09.750462v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Antibacterial activity of a newly identified phage-derived endolysin and its parental bacteriophage against clinical uropathogenic Escherichia coli
AU - W. Wesolowski
AU - S. Bloch
AU - G. Czerwonka
AU - E. Jagiela
AU - L. Grabowski
AU - M. Jeschke
AU - J. Jacewicz
AU - E. Piwnicka
AU - J. Morcinek-Orlowska
AU - H. Loika
AU - P. Czaplewska
AU - G. Wegrzyn
AU - W. Adamus-Bialek
AU - A. Lukasiak
AU - B. Nejman-Falenczyk
PY - 2026
DA - 2026/09/09
PB - bioRxiv
DO - 10.64898/2026.09.09.750462
UR - https://www.biorxiv.org/content/10.64898/2026.09.09.750462v1
AB - The increasing prevalence of antibiotic-resistant uropathogenic Escherichia coli highlights the need for antibacterial strategies that can complement or extend beyond conventional antibiotic treatment. Bacteriophages and phage-derived lytic enzymes represent promising alternatives because of their distinct mechanisms of bacterial killing and their potential activity against drug-resistant pathogens. In this study, we characterized the newly discovered UPEC-infecting bacteriophage vB-EcoS_57-3 and the endolysin 57_3Lys, encoded by this phage, combining genomic, structural, and functional approaches. The phage demonstrated lytic activity against clinical UPEC isolates and retained antibacterial potential under conditions relevant to the urinary tract. Genomic and sequence analyses revealed distinctive features of 57_3Lys associated with signal-anchor-release endolysins and suggested a less common mode of intracellular translocation and activation. Functional experiments supported the involvement of the bacterial secretion machinery in endolysin-mediated lysis. Notably, the purified enzyme also displayed antibacterial activity against intact clinical E. coli cells, despite the intrinsic barrier presented by the Gram-negative cell envelope. Although this activity developed slowly, it significantly reduced both bacterial culture turbidity and viable cell number. Together, these findings provide new insights into the antimicrobial strategies based on the phages and their phage lytic enzymes, supporting further exploration of vB-EcoS_57-3 and 57_3Lys as potential tools against antibiotic-resistant UPEC.
ER -